A Phase 1/2, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of INX-315 in Patients With Advanced Cancer
This clinical trial is testing a new experimental medication called INX-315 for adults with advanced cancers, particularly certain types of breast and ovarian cancers. Researchers want to see if this medication is safe, figure out the right dose, and check if it helps shrink tumors when given alone or with other approved therapies.
You might be able to join if you have advanced breast cancer, ovarian cancer, or other solid tumors that have continued to grow after trying standard treatments. Participants also need to be well enough to carry out their normal daily activities.
Participants will receive the study medication, which is taken by mouth, either by itself or combined with other standard cancer therapies like hormone treatments. Your health care team will monitor you very closely with regular check-ins and imaging scans to see how your body and the cancer respond to the treatment.
This study is currently recruiting patients at medical centers in locations such as Orlando, Florida, and Atlanta and Augusta, Georgia.
- 1Testing a new cancer medication called INX-315
- 2Focuses on advanced breast and ovarian cancers that stopped responding to standard treatments
- 3Currently recruiting patients at select locations in Florida and Georgia
No related links yet
Seen this study covered in the news, or found a page that explains it well? Send it over and we'll review it.
Suggest a linkThis summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.